CNO Financial Group Inc
NYSE:CNO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
35.49
43.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
CNO Financial Group Inc
CNO Financial Group Inc., based in Carmel, Indiana, stands as a testament to the resilient nature of the insurance and financial services industry in America. Established in 1979, originally as Conseco, the company has navigated through various market upheavals and strategic pivots to bolster its position in serving the health and financial security needs of middle-income Americans and retirees. Its subsidiaries, including Bankers Life, Colonial Penn, and Washington National, form the core through which CNO extends its insurance products, including life insurance and supplemental health insurance, along with annuities across the nation. These subsidiaries operate through a network of dedicated agents and brokers, ensuring a broad reach into communities often underserved by larger, more generalized insurance companies.
CNO Financial Group’s operational strategy hinges on balancing risk management with customer-centric innovation. By tailoring its offerings to meet the specific needs of its demographic, CNO not only generates revenue through premiums but also through the strategic investment of those premiums. This investment income forms a dual stream of revenue, ensuring stability and growth. Moreover, the company's approach has been to maintain strong capital reserves, underpinned by prudent underwriting and disciplined expense management, to protect policyholder interests and shareholder value. By continually adapting to changes in demographic trends and regulatory environments, CNO Financial Group demonstrates the ability to sustain and enhance its business model in an ever-evolving marketplace.
CNO Financial Group Inc., based in Carmel, Indiana, stands as a testament to the resilient nature of the insurance and financial services industry in America. Established in 1979, originally as Conseco, the company has navigated through various market upheavals and strategic pivots to bolster its position in serving the health and financial security needs of middle-income Americans and retirees. Its subsidiaries, including Bankers Life, Colonial Penn, and Washington National, form the core through which CNO extends its insurance products, including life insurance and supplemental health insurance, along with annuities across the nation. These subsidiaries operate through a network of dedicated agents and brokers, ensuring a broad reach into communities often underserved by larger, more generalized insurance companies.
CNO Financial Group’s operational strategy hinges on balancing risk management with customer-centric innovation. By tailoring its offerings to meet the specific needs of its demographic, CNO not only generates revenue through premiums but also through the strategic investment of those premiums. This investment income forms a dual stream of revenue, ensuring stability and growth. Moreover, the company's approach has been to maintain strong capital reserves, underpinned by prudent underwriting and disciplined expense management, to protect policyholder interests and shareholder value. By continually adapting to changes in demographic trends and regulatory environments, CNO Financial Group demonstrates the ability to sustain and enhance its business model in an ever-evolving marketplace.
Strong Quarter: CNO delivered another strong quarter with record new annualized premiums of $125 million, up 26%, and double-digit insurance sales growth in both divisions.
EPS Growth: Operating earnings per share rose to $1.29, up 16% year-over-year, aided by favorable insurance margins and solid investment results.
Strategic Actions: Management is exiting the loss-making Worksite fee services business and executed a second Bermuda reinsurance treaty, both expected to boost ROE by 50 bps by 2027.
Guidance Raised: 2027 operating ROE target increased to 200 bps above 2024’s 10% run rate (was 150 bps), and excess cash flow guidance to the holding company was raised to $365–385 million.
Capital Returns: $76 million was returned to shareholders in the quarter and $310 million year-to-date, with share repurchases reducing diluted shares outstanding by 8%.
Impairment & Exit Charges: A $96.7 million impairment was recorded for the exiting fee services business, with additional exit charges of $15–20 million expected in Q4 2025.
Positive Sales Trends: Insurance product sales remain strong in both Consumer and Worksite divisions, with sustained agent growth and productivity improvements.
Medicare Product Shift: A shift is underway from Medicare Advantage to Medicare Supplement, reflecting consumer preferences and market trends.